Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000224150 | SCV000281061 | likely benign | not provided | 2017-08-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001837463 | SCV000284752 | benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000443322 | SCV000521117 | benign | not specified | 2016-11-25 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory of Genetics and Molecular Cardiology, |
RCV000157118 | SCV000588450 | likely benign | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | |
Fundacion Hipercolesterolemia Familiar | RCV000157118 | SCV000607382 | likely benign | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | |
Color Diagnostics, |
RCV000157118 | SCV000687188 | likely benign | Hypercholesterolemia, familial, 1 | 2017-06-27 | criteria provided, single submitter | clinical testing | |
Robarts Research Institute, |
RCV000157118 | SCV000782786 | benign | Hypercholesterolemia, familial, 1 | 2018-01-02 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000224150 | SCV001133382 | benign | not provided | 2023-06-05 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001137197 | SCV001297112 | likely benign | Hypercholesterolemia, autosomal dominant, type B | 2018-01-29 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Ce |
RCV000224150 | SCV002544002 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | APOB: BP4, BS1, BS2 |
Ambry Genetics | RCV002381506 | SCV002691857 | benign | Cardiovascular phenotype | 2016-01-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000224150 | SCV003799738 | benign | not provided | 2023-09-21 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000224150 | SCV005262626 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Blueprint Genetics | RCV000157118 | SCV000206841 | likely benign | Hypercholesterolemia, familial, 1 | 2014-12-02 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV000443322 | SCV001921336 | benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000224150 | SCV001962750 | likely benign | not provided | no assertion criteria provided | clinical testing |